Dr Nikki Burdett
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
25 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
Comparison of homologous recombination deficiency scoring methods in multi-site samples in high grade serous ovarian cancer
DOI: 10.1016/j.ijgc.2025.1042332026
Journal article
Rethinking ovarian cancer III: the past decade and future directions
DOI: 10.1038/s41568-026-00916-02026
Research grants (ARC, NHMRC, MRFF)
Identifying the Key to Treatment Resistance in Ovarian Cancer
2026
Research grants (other domestic)
Targeting Whole Genome Doubling as a Therapeutic Vulnerability in Ovarian Cancer
2025
Journal article
Abstract B004: Evaluating spatial inter-tumor heterogeneity in whole genome duplication states and homologous recombination deficiency status in advanced ovarian high grade serous carcinoma
DOI: 10.1158/1538-7445.ovarian25-b0042025
Journal article
Genome doubling fuels ovarian cancer evolution and immune dysregulation
DOI: 10.1038/d41586-025-02059-y2024
Research grants (other domestic)
Stereotactic Ablative Body Radiotherapy (SABR) for 4 Gynaecologic Metastases
RECENT SCHOLARLY WORKS
2024
Journal article
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer
DOI: 10.1038/s41467-024-50137-y2024
Journal article
Planetary care is good cancer care
DOI: 10.5694/mja2.524552024
Conference Proceedings
EV243/#1235 Genomic characteristics underlying homologous recombination deficient-negative scores in ovarian high grade serous cancer tumors
DOI: 10.1136/ijgc-2024-igcs.3622024
Conference Proceedings
Beacon: A phase II study of bevacizumab, atezolizumab, and cobimetinib in patients with recurrent, platinum resistant, high grade serous ovarian cancer.
DOI: 10.1200/JCO.2024.42.16_suppl.55652024
Conference Proceedings
Inter-tumor heterogeneity revealed by multi-site whole genome sequencing of high grade serous ovarian cancer
DOI: 10.1158/1538-7445.OVARIAN23-A0572024
Conference Proceedings
Effect of spatial and temporal inter-tumoral heterogeneity on homologous recombination deficiency scores in high grade serous ovarian cancer
DOI: 10.1158/1538-7445.OVARIAN23-B114